Baker Brothers Advisors - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$8,851,000
-0.2%
69,9660.0%0.05%
-2.0%
Q1 2022$8,871,000
-3.2%
69,9660.0%0.05%
+13.3%
Q4 2021$9,166,000
+7.1%
69,9660.0%0.04%
+18.4%
Q3 2021$8,559,000
+7.3%
69,9660.0%0.04%
+8.6%
Q2 2021$7,975,000
-5.2%
69,9660.0%0.04%
-2.8%
Q1 2021$8,412,000
+18.3%
69,9660.0%0.04%
+33.3%
Q4 2020$7,108,000
+18.2%
69,966
-10.0%
0.03%
+12.5%
Q3 2020$6,014,000
-34.2%
77,776
-5.1%
0.02%
-40.0%
Q2 2020$9,137,000
+202.3%
81,976
+95.3%
0.04%
+110.5%
Q1 2020$3,022,00041,9760.02%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders